These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11900945)

  • 1. The use of linezolid in the treatment of vancomycin-resistant enterococcal septicaemia in two patients with burn injuries.
    Atkins JL; Hidvegi N; Teare L; Dziewulski P
    Burns; 2002 Mar; 28(2):185-8. PubMed ID: 11900945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
    Smith RL; Evans HL; Chong TW; McElearney ST; Hedrick TL; Swenson BR; Scheld WM; Pruett TL; Sawyer RG
    Surg Infect (Larchmt); 2008 Aug; 9(4):423-31. PubMed ID: 18759679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
    Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
    Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
    Noskin GA
    Ann Acad Med Singap; 2001 May; 30(3):320-31. PubMed ID: 11455748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitis.
    Broder KW; Moise PA; Schultz RO; Forrest A; Schentag JJ
    Ann Plast Surg; 2004 Apr; 52(4):385-90. PubMed ID: 15084884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid in children: recent patents and advances.
    Velissariou IM
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):73-7. PubMed ID: 18221164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
    Wilcox MH
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
    Corti G; Cinelli R; Paradisi F
    Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
    Vinken A; Li Z; Balan D; Rittenhouse B; Wilike R; Nathwani D
    J Hosp Infect; 2001 Dec; 49 Suppl A():S13-24. PubMed ID: 11926436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
    Alaniz C; Pogue JM
    Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
    Hayakawa K; Marchaim D; Pogue JM; Ho K; Parveen S; Nanjireddy P; Sunkara B; Singla M; Jagadeesh KK; Moshos JA; Bommarito S; Mroue R; Farhat M; Obeid T; Chaudhry A; Vadlamudi G; Lephart PR; Martin ET; Rybak MJ; Kaye KS
    Am J Infect Control; 2012 Dec; 40(10):e261-3. PubMed ID: 23199727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
    Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
    Patel R; Gallagher JC
    Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.